Zdrowie i gospodarka · 11.03.1994
Advisory Committee Meeting; Amendment of Notice
The FDA is amending the meeting of the Cardiovascular and Renal Drugs Advisory Committee, originally scheduled for March 24-25, 1994, to change meeting times and revise the agenda for the open committee discussion on March 25, 1994.